ZAR1 and cancer: Cancer cell lines (A427, A549, H322, HTB171 and HeLa) with ZAR1 promoter hypermethylation (Figs. 1c, d and 4a) and missing ZAR1 expression (Fig. 1a, b) were chosen for testing reexpression of ZAR1 under demethylation treatment.